Home / Investors / Business development / Siemens’ ELISA business portfolio acquisition

Siemens’ ELISA business portfolio acquisition

How it works

Acquisition of a product portfolio based on the ELISA immunodiagnostic technology from Siemens and access to Siemens' ELISA clients.

Category
Acquisitions
Technology
Immunodiagnostics
pdfPress release443.45KB

Carlo Rosa

CEO

We are very excited to acquire the Siemens Healthineers ELISA business. We think this deal would perfectly fit with our long-term strategy aimed at expanding our customer base leveraging on our extensive CLIA specialities menu and LIAISON Platforms.

Rationale
Convert clients adopting Siemens’ ELISA products to our proprietary CLIA solutions, leveraging on the completeness of our CLIA menu and our LIAISON platforms.